v3.26.1
Segment Reporting - Schedule of Segment Revenue, Segment Profit and Segment Expenses (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting Information [Line Items]        
Total revenues $ 307,959 $ 264,566 $ 576,021 $ 508,882
Cost of product sales 28,316 20,734 53,107 41,126
Research and development 81,555 77,951 158,423 156,216
Selling, general and administrative 160,252 133,507 331,271 259,877
Interest income, net 7,990 7,243 16,045 15,144
Other income 647 594 1,189 1,183
Income tax expense 14,973 13,545 15,317 22,337
Net Income (Loss) 31,500 26,666 35,137 45,653
Reportable Segment [Member]        
Segment Reporting Information [Line Items]        
Total revenues 307,959 264,566 576,021 508,882
Cost of product sales 12,785 8,384 24,449 17,595
License fees and royalties 15,531 12,350 28,658 23,531
Research and development 81,555 77,951 158,423 156,216
Selling, general and administrative 160,252 133,507 331,271 259,877
Interest income, net (7,990) (7,243) (16,045) (15,144)
Other income (647) (594) (1,189) (1,183)
Income tax expense 14,973 13,545 15,317 22,337
Net Income (Loss) 31,500 26,666 35,137 45,653
Reportable Segment [Member] | External research and development        
Segment Reporting Information [Line Items]        
Research and development 55,395 54,319 104,218 109,304
Reportable Segment [Member] | Internal costs        
Segment Reporting Information [Line Items]        
Research and development [1] 26,160 23,632 51,704 46,912
Reportable Segment [Member] | Upfront And Milestone Payments        
Segment Reporting Information [Line Items]        
Research and development 0 0 2,501 0
NUPLAZID | Reportable Segment [Member]        
Segment Reporting Information [Line Items]        
Total revenues 183,132 168,479 350,056 328,199
DAYBUE products | Reportable Segment [Member]        
Segment Reporting Information [Line Items]        
Total revenues $ 124,827 $ 96,087 $ 225,965 $ 180,683
[1] Includes personnel expenses and costs allocated to multiple research and development programs, including benefits, information technology, facilities and inventory.